Search

Your search keyword '"Day, John"' showing total 441 results

Search Constraints

Start Over You searched for: Author "Day, John" Remove constraint Author: "Day, John" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
441 results on '"Day, John"'

Search Results

1. Learning 3D object-centric representation through prediction

2. Succession law

4. Planetary Exploration Horizon 2061 Report Chapter 5: Enabling technologies for planetary exploration

5. Histology of the Porous Oculomotorius: Relevance to Anterior Skull Base Approaches

7. Global dataset of soil organic carbon in tidal marshes

8. Cardiac and pulmonary findings in dysferlinopathy: A 3‐year, longitudinal study

10. Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)

11. Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy.

12. Maturation of the internal auditory canal and posterior petrous bone with relevance to lateral and posterolateral skull base approaches.

14. Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT)

15. Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA)

16. Increased tissue stiffness triggers contractile dysfunction and telomere shortening in dystrophic cardiomyocytes

20. Co-located ecological data for exploring top- and subsoil carbon dynamics across grassland-woodland contrasts

21. Bulbar function in spinal muscular atrophy (SMA): State of art and new challenges. 21st July 2023, Rome, Italy

22. Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA

24. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

26. Contributors

27. Enabling technologies for planetary exploration

28. Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI pattern

29. Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial

30. Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy

33. Introduction

37. Recursive InterNetwork Architecture, Investigating RINA as an Alternative to TCP/IP (IRATI)

38. Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

40. Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint Hypermobility

45. Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes

47. Conformational fingerprinting with Raman spectroscopy reveals protein structure as a translational biomarker of muscle pathology.

49. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Catalog

Books, media, physical & digital resources